cancer, genetics & genomics, clinical trials

The publicly available database found nearly a third of samples included mutations targeted by either approved drugs or therapies in clinical trials. 

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

Advances in genomics and cancer biology will alter the design of human cancer studies.

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.